195 related articles for article (PubMed ID: 37307574)
1. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
Dwivedi AK; Vishwakarma D; Dubey P; Reddy S
Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574
[TBL] [Abstract][Full Text] [Related]
2. Trends, Predictors, and Outcomes of Cardiovascular Complications Associated With Polycystic Ovary Syndrome During Delivery Hospitalizations: A National Inpatient Sample Analysis (2002-2019).
Zahid S; Khan MZ; Gowda S; Faza NN; Honigberg MC; Vaught AJ; Guan C; Minhas AS; Michos ED
J Am Heart Assoc; 2022 Aug; 11(16):e025839. PubMed ID: 35708290
[TBL] [Abstract][Full Text] [Related]
3. Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations.
Dubey P; Reddy S; Singh V; Yousif A; Dwivedi AK
BMC Med; 2024 May; 22(1):208. PubMed ID: 38783294
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
5. Irregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort.
Wang Z; Jukic AMZ; Baird DD; Wilcox AJ; Li H; Curry CL; Fischer-Colbrie T; Onnela JP; Williams MA; Hauser R; Coull BA; Mahalingaiah S
JAMA Netw Open; 2024 May; 7(5):e249657. PubMed ID: 38700861
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
7. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
8. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring.
Doherty DA; Newnham JP; Bower C; Hart R
Obstet Gynecol; 2015 Jun; 125(6):1397-1406. PubMed ID: 26000511
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome: associations with cardiovascular disease.
Benham JL; Goldberg A; Teede H; Tay CT
Climacteric; 2024 Feb; 27(1):47-52. PubMed ID: 38073517
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.
Wang ET; Calderon-Margalit R; Cedars MI; Daviglus ML; Merkin SS; Schreiner PJ; Sternfeld B; Wellons M; Schwartz SM; Lewis CE; Williams OD; Siscovick DS; Bibbins-Domingo K
Obstet Gynecol; 2011 Jan; 117(1):6-13. PubMed ID: 21173640
[TBL] [Abstract][Full Text] [Related]
12. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome.
Alur-Gupta S; Boland MR; Dokras A;
Fertil Steril; 2023 May; 119(5):847-857. PubMed ID: 36693555
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C; Zahid S; Minhas AS; Ouyang P; Vaught A; Baker VL; Michos ED
Fertil Steril; 2022 May; 117(5):924-935. PubMed ID: 35512976
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
[TBL] [Abstract][Full Text] [Related]
15. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome.
Taylor MC; Reema Kar A; Kunselman AR; Stetter CM; Dunaif A; Legro RS
Hum Reprod; 2011 Aug; 26(8):2226-31. PubMed ID: 21505042
[TBL] [Abstract][Full Text] [Related]
16. Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease.
Dubey P; Reddy S; Sharma K; Johnson S; Hardy G; Dwivedi AK
Curr Cardiol Rep; 2024 Jun; 26(6):483-495. PubMed ID: 38568339
[TBL] [Abstract][Full Text] [Related]
17. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
[TBL] [Abstract][Full Text] [Related]
19. Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study.
Berni TR; Morgan CL; Rees DA
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3369-e3380. PubMed ID: 34061968
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
